GENPHARM is a specialty pharmaceutical company based in Dubai, serving the Middle East and North Africa (MENA) region. We are committed to bringing therapeutic solutions to patients with rare genetic diseases, orphan drugs, and specialty therapeutics. As a preferred commercial partner, we offer a range of services including pharmaceutical market access, business development, distribution, and consultancy in the MENA region.

Our expertise lies in specialty and rare diseases, making us the go-to partner for market access in this field. At GENPHARM, we prioritize patient centricity, ensuring that our daily tasks are driven by a sense of urgency to serve patients and their families. We operate through long-term strategic partnerships, connecting with pharma leaders worldwide to bring the best therapeutic solutions to our patients.

Our extensive regional expertise, trusted network, and knowledge of the local business culture facilitate the understanding and access to the MENA market. With a focus on gene therapy and cell therapy, we strive to be at the forefront of medical advancements. Our goal is to be the first to bring these groundbreaking cures to our patients and address unmet medical needs.

We work closely with stakeholders, regulators, physicians, and patients to make a difference in the lives of those affected by rare diseases. To stay up to date with the latest trends and partnerships, follow our Twitter feed and explore our news archive. We are proud to be a trusted partner in the MENA region, committed to providing innovative healthcare solutions and improving the lives of patients